Nano robot

Abstract

The invention relates to a nano robot which comprises a loading component, a power component and a connecting component, wherein the loading component is used for loading a tagging reagent; the power component is used for generating power according to environmental conditions, and the direction of the power is the direction away from the loading component; and the connecting component is respectively connected with the loading component and the power component, so that the power component seals the loading component, and is disconnected when the power is greater than the preset value. According to the technical scheme of the embodiment of the invention, since the power component can generate power according to the environmental conditions, the user can set the environmental conditions according to needs, so that the power generated by the power component is greater than the preset value on demand; and thus, the connecting component is broken, the power component departs from the loading component, and the tagging reagent in the loading component flows out, thereby tagging the sick cells. Therefore, the doctor can accurately determine the distribution of the sick cells in the patient body, thereby determining the state of illness and treating the disease.

Description

technical field [0001] The invention relates to the field of medical technology, in particular to a nanorobot. Background technique [0002] Most of the existing anticancer drugs enter the human body through oral administration, infusion, etc. While inhibiting and killing cancer cells, they also have the same effect on normal cells in the human body, seriously affecting the health of patients. For example, bleomycin, mitomycin and other drugs are currently commonly used anticancer drugs, but their side effects are obvious, and they are likely to cause various symptoms such as anemia and vomiting. Therefore, direct use is not conducive to the health of patients and is not conducive to Diagnosis and treatment of cancer. [0003] In order to effectively treat cancer, tumor-specific markers such as alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), and neuron-specific enolase (NSE) are used in the prior art to mark cancer cells, but the above-mentioned markers All of the...

AI Technical Summary

Problems solved by technology

[0002] Most of the existing anticancer drugs enter the human body through oral administration, infusion, etc. While inhibiting and killing cancer cells, they also have the same effect on normal cells in the human body, seriously affecting the health of patients

For example, bleomycin, mitomycin and other drugs are currently commonly used anticancer drugs, but their side effects are obvious, and they are likely to cause various symptoms such as anemia and vomiting. Therefore, direct use is not conducive to the health of patients and is not conducive to Cancer Treatment

[0003] In order to effectively treat cancer, tumor-specific markers such as alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), and neuron-specific enolase (NSE) are used in the prior art to mark cancer cells, but the above-mentioned markers All of them lack versatility, can only reflect a few or one kind of malignant tumors, have no diagnostic value for other malignant tumors, and the marking process is uncontrollable, so it is difficult to carry out targeted marking according to user needs

Images